SABCS 2021 Conference Coverage on VuMedi

 

SABCS 2021 Conference Coverage on VuMedi
A

Oral SERD Elacestrant vs. Investigator’s Choice of Endocrine Monotherapy for ER+/HER2- mBC Following Progression on Prior ET & CDK4/6i: Results of EMERALD Phase 3 Trial

By SABCS 2021 Conference Coverage on VuMedi FEATURING Aditya Bardia
By SABCS 2021 Conference Coverage on VuMedi FEATURING Aditya Bardia
298 views
February 4, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

06:14
Lilly Medical Affairs

CDK4/6 Inhibitors as First-Line Treatment for HR+, HER2- MBC

Feat. J. O’Shaughnessy

Featured Video

03:38
Lilly Medical Affairs

SERDS: Relevance and Role in Current & Future Treatments for HR+…

Feat. K. Jhaveri
Videos
08:12

SABCS 2021 Evaluation of Tucatinib + (Paclitaxel + Pertuzumab + Tras…

SABCS 2021 Conference Coverage on VuMedi

D. Potter

197 views
18:03

Final Findings From the CONTROL Trial of Diarrheal Prophylaxis or Ne…

SABCS 2021 Conference Coverage on VuMedi

C. Barcenas

196 views
11:18

Oral SERD Elacestrant vs. Investigator’s Choice of Endocrine Monothe…

SABCS 2021 Conference Coverage on VuMedi

A. Bardia

298 views
13:40

Optimizing Use of HER2 Therapies in MBC

SABCS 2021 Conference Coverage on VuMedi

P. Sharma

194 views
08:21

Examination of Low HER2 Expression in Breast Cancer

SABCS 2021 Conference Coverage on VuMedi

A. Fernandez

132 views
05:44

SABCS 2021 on CNS Metastases as a Site of First Recurrence in Adjuva…

SABCS 2021 Conference Coverage on VuMedi

N. Lin

1.2K views
06:59

SABCS 2021 Update on the KEYNOTE-522 Trial of Neoadjuvant Pembro+Che…

SABCS 2021 Conference Coverage on VuMedi

P. Schmid

235 views
08:19

SABCS 2021 Interim Analysis of the PREDICT Registry: Changes in Trea…

SABCS 2021 Conference Coverage on VuMedi

P. Whitworth

272 views
04:20

SABCS 2021 on Sacituzumab Govitecan in mTNBC: Post-Progression Thera…

SABCS 2021 Conference Coverage on VuMedi

J. Cortes

239 views
10:39

SABCS 2021 KEYNOTE-355 Final Results: Efficacy of Pembro+Chemo vs. P…

SABCS 2021 Conference Coverage on VuMedi

J. Cortes

467 views
09:07

SABCS 2021 on MRI Screening vs. SYMptom-Directed Surveillance for Br…

SABCS 2021 Conference Coverage on VuMedi

K. Jerzak

397 views
07:02

SABCS 2021 Updated Results of Tucatinib vs. Placebo Added to Trastuz…

SABCS 2021 Conference Coverage on VuMedi

N. Lin

977 views
25:09

SABCS 2021 on Using the Appearance of a Resistance Mutation in Perip…

SABCS 2021 Conference Coverage on VuMedi

S. Vogl

479 views
32:47

SABCS 2021 Updated Results From the RxPONDER Trial in HR+/HER2- Brea…

SABCS 2021 Conference Coverage on VuMedi

S. Vogl

1.4K views
06:26

SABCS 2021 Update on the Clinical Utility of Genomic Profiling in MB…

SABCS 2021 Conference Coverage on VuMedi

F. Andre

338 views
11:25

SABCS 2021 PROs in ECOG-ACRIN EA1131: Platinum vs. Capecitabine in R…

SABCS 2021 Conference Coverage on VuMedi

K. Lisa Smith

278 views
14:35

SABCS 2021 Update on QoL Results From OlympiA Trial: Adjuvant Olapar…

SABCS 2021 Conference Coverage on VuMedi

P. Ganz

290 views
10:48

Update on T-DXd vs. T-DM1 in HER2+ MBC: Subgroup Analyses From the P…

SABCS 2021 Conference Coverage on VuMedi

S. Hurvitz

904 views
06:17

SABCS 2021: Does Chemotherapy Benefit Patients With HR+/HER2- ILBC?

SABCS 2021 Conference Coverage on VuMedi

M. Yaghi

1.5K views
07:16

SABCS 2021 Results of a Prospective Screening Study: Impact of Race …

SABCS 2021 Conference Coverage on VuMedi

A. Barrio

13 views
24:23

SABCS 2021 Updates on Refining Axillary Management After Neoadjuvant…

SABCS 2021 Conference Coverage on VuMedi

T. Mamounas

801 views
11:50

SABCS 2021 Update on Samuraciclib, a First-in-Class, Oral, Selective…

SABCS 2021 Conference Coverage on VuMedi

C. Coombes

333 views
13:08

SABCS 2021 Updates on Neratinib + Fulvestrant + Trastuzumab for HR+/…

SABCS 2021 Conference Coverage on VuMedi

K. Jhaveri

277 views
04:56

SABCS 2021 Update on Ipatasertib + Palbociclib and Fulvestrant in HR…

SABCS 2021 Conference Coverage on VuMedi

M. Oliveira

292 views
07:38

SABCS 2021 Update on T-DXd vs.T-DM1 in High-Risk HER2+ Residual Inva…

SABCS 2021 Conference Coverage on VuMedi

C. Geyer

503 views
04:45

SABCS 2021 Presentation on the Detection of ctDNA Post Neoadjuvant C…

SABCS 2021 Conference Coverage on VuMedi

M. Ignatiadis

401 views
24:21

SABCS 2021 Update on Oligoprogressive Disease in BC: Treating Locall…

SABCS 2021 Conference Coverage on VuMedi

A. Xu

505 views
05:24

SABCS 2021 Detection of Early Stage BC Recurrence Using a Personaliz…

SABCS 2021 Conference Coverage on VuMedi

W. Janni

227 views
06:06

SABCS 2021 MammaPrint and BluePrint Are Prognostic of Outcome Follow…

SABCS 2021 Conference Coverage on VuMedi

A. Chung

324 views
12:37

SABCS 2021 Update on Adjuvant Palbociclib in HR+/HER2- EBC: Final Re…

SABCS 2021 Conference Coverage on VuMedi

M. Gnant

546 views
08:18

SABCS 2021 Update on T-DXd in Patients With HER2+ or HER2-Low-Expres…

SABCS 2021 Conference Coverage on VuMedi

M. Vaz Batista

325 views
19:53

SABCS 2021 Update on IO and mTNBC: Which Chemo-Backbone and Biomarke…

SABCS 2021 Conference Coverage on VuMedi

R. Dent

445 views